135 related articles for article (PubMed ID: 1109788)
1. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
2. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
3. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
Wile AG; Sparks FC; Morton DL
Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
[TBL] [Abstract][Full Text] [Related]
4. [Development in the immunotherapy of malignant melanoma].
Tritsch H
Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
[TBL] [Abstract][Full Text] [Related]
5. Production of antisera with specificity for malignant melanoma and human fetal skin.
Fritze D; Kern DH; Drogemuller CR; Pilch YH
Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
[TBL] [Abstract][Full Text] [Related]
6. "Hidden" cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera.
Morgan AC; Rossen RD; McCormick KJ; Stehlin JS; Giovanella BC
Cancer Res; 1982 Mar; 42(3):881-7. PubMed ID: 7059986
[TBL] [Abstract][Full Text] [Related]
7. [In vitro humeral serum cytotoxic reactions in melanoma].
Korosteleva TA; Veresova OV; Khachaturyan LM
Vopr Onkol; 1979; 25(9):12-4. PubMed ID: 483712
[TBL] [Abstract][Full Text] [Related]
8. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
9. Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
Catapano MS; Brown JM; Rosenberg SA
Cancer Res; 1980 Apr; 40(4):979-83. PubMed ID: 6928402
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in complement-dependent cytotoxicity.
Hellström I; Brown JP; Hellström KE
J Immunol; 1981 Jul; 127(1):157-60. PubMed ID: 6787119
[TBL] [Abstract][Full Text] [Related]
11. [Humoral antitumor cytotoxins in patients with melanoma of the skin].
Korosteleva TA; Veresova OV; Khachaturian LM
Vopr Onkol; 1975; 21(5):61-3. PubMed ID: 1210146
[TBL] [Abstract][Full Text] [Related]
12. Immunological changes in cancer patients receiving BCG.
Cochran AJ; Mackie RM; Jackson AM; Ogg LJ; Ross CE
Dev Biol Stand; 1977 Apr 13-15; 38():441-8. PubMed ID: 608535
[TBL] [Abstract][Full Text] [Related]
13. [Anti-tumor antibodies in the blood of patients with gliomas].
Martin-Achard A; Diserens AC; de Tribolet N; Zander E; Carrel S
Schweiz Med Wochenschr; 1978 Jun; 108(25):959-62. PubMed ID: 663586
[TBL] [Abstract][Full Text] [Related]
14. Blood group A-like activity in a long-term renal cell line.
Leet DC; Kuhns WJ; Avis I; Avis FP
Invest Urol; 1980 Jan; 17(4):305-9. PubMed ID: 7351362
[TBL] [Abstract][Full Text] [Related]
15. Immunological factors which influence response to immunotherapy in malignant melanoma.
Morton D; Eilber FR; Malmgren RA; Wood WC
Surgery; 1970 Jul; 68(1):158-63; discussion 163-4. PubMed ID: 10483463
[TBL] [Abstract][Full Text] [Related]
16. Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells.
Dippold WG; Knuth A; Meyer zum Büschenfelde KH
Behring Inst Mitt; 1984 May; (74):14-8. PubMed ID: 6332614
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic antibody reactivity in sera of melanoma patients against allogeneic and autologous cultured tumor cells and fibroblasts.
Brown JM; Shoffner PC; Tondreau SP; Matthews EJ; Terry WD; Rosenberg SA
Cancer Res; 1982 Jun; 42(6):2216-22. PubMed ID: 7074602
[No Abstract] [Full Text] [Related]
18. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].
Takeyama H; Watanabe T; Livingston PO
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307
[TBL] [Abstract][Full Text] [Related]
19. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF
Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593
[TBL] [Abstract][Full Text] [Related]
20. Immunological studies on malignant melanomas of man.
Romsdahl MM; Cox IS
Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
[No Abstract] [Full Text] [Related]
[Next] [New Search]